Total Transcatheter Stage 1: A Word of Caution

Stephen Nageotte, Shabana Shahanavaz, Pirooz Eghtesady, David Balzer

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

For patients with single ventricle physiology, being able to initially establish systemic blood flow and control pulmonary blood flow is critical to their long-term health. Recently, there have been descriptions in achieving this by a purely transcatheter approach with stenting of the ductus arteriosus and implanting pulmonary flow restrictors, a very appealing prospect. We review a case series of 6 patients who underwent a percutaneous modified stage 1 approach using modified Microvascular plugs (MVP) at our center between September 2019 and December 2019. The initial procedure was technically successful in all patients with single-stage ductal stenting and placement of bilateral modified MVP via femoral access. Four patients underwent repeat cardiac catheterization prior to subsequent surgery that demonstrated elevated Qp:Qs (> 2:1) in 3 of the 4 patients with an elevated mean distal PA pressure > 20 mmHg in all patients. In some patients, the device migrated into the distal right pulmonary artery. One patient after Glenn shunt was found to have significant LPA stenosis requiring stenting. While the percutaneous modified stage 1 approach is a promising approach, we offer a word of caution against widespread adoption of this technique with the currently available devices.

Original languageEnglish
Pages (from-to)1410-1415
Number of pages6
JournalPediatric Cardiology
Volume42
Issue number6
DOIs
StatePublished - Aug 2021

Keywords

  • Flow restrictor
  • Percutaneous modified stage 1
  • Single ventricle

Fingerprint

Dive into the research topics of 'Total Transcatheter Stage 1: A Word of Caution'. Together they form a unique fingerprint.

Cite this